Press release
Pharmaceutical Contract Development & Manufacturing Market worth $222.04 billion by 2030, growing at a CAGR of 8.46% - Exclusive Report by 360iResearch
Pharmaceutical Contract Development & Manufacturing Market | 360iResearch
The Global Pharmaceutical Contract Development & Manufacturing Market to grow from USD 125.73 billion in 2023 to USD 222.04 billion by 2030, at a CAGR of 8.46%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/pharmaceutical-contract-development-manufacturing?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Pharmaceutical contract development and manufacturing (CDMO) refers to outsourcing drug development and manufacturing processes to third-party organizations. CDMO services cover a broad range of activities, including drug discovery, formulation development, process optimization, scale-up, regulatory submission support, and the eventual manufacturing of the final product for clinical trials or commercial distribution. Pharmaceutical companies can concentrate on their core competencies, such as drug discovery and marketing, by outsourcing to CDMOs while gaining access to cutting-edge technologies and regulatory expertise. The applications for contract development and manufacturing span the entire lifecycle of pharmaceutical products. The increasing trend of pharmaceutical outsourcing due to cost reduction and efficiency gains and expanding pipelines of biopharmaceutical companies requiring specialized manufacturing capabilities have increased the demand for pharmaceutical contract development and manufacturing. In addition, the globalization of the pharmaceutical industry drives the need for local manufacturing facilities to navigate regulatory landscapes, developing a growing need for pharmaceutical contract development and manufacturing services. However, regulatory challenges and compliance costs associated with varying international standards and complexities in supply chain management and logistics can negatively affect the pharmaceutical contract development and manufacturing market. Nevertheless, the emergence of personalized medicine and next-generation therapies creates opportunities for pharmaceutical contract development and manufacturing. Moreover, investments by vendors in advanced manufacturing technologies such as continuous manufacturing and single-use systems are expected to make pharmaceutical contract development and manufacturing an attractive option for end-users.
Asia-Pacific is a rapidly growing market for pharmaceutical contract development and manufacturing organizations (CDMOs) fueled by increasing healthcare expenditure and supportive government policies. The emerging economies in the Asia-Pacific are investing heavily in biotechnology and are known for their generic pharmaceutical manufacturing capabilities. China's "Made in China 2025" plan and India's government aim to advance their domestic pharmaceutical sectors, influencing CDMO activities in the Asia-Pacific. The Americas region is a maturing market for pharmaceutical CDMOs characterized by high spending on health services, extensive R&D activities, and many biotechnology and pharmaceutical companies. Consumers in the Americas expect high-quality products, prioritizing regulatory compliance. This has led CDMOs to invest in advanced manufacturing technologies and capabilities to cater to these market needs. The European Union is a significant hub for high-quality pharmaceutical manufacturing and innovation. A strong emphasis on quality and compliance with Good Manufacturing Practice (GMP) standards has improved access to various advanced drug modalities. Recent patents in the EMEA region are focused on pharmaceutical formulations and advanced delivery systems. The Middle East and parts of Africa are emerging markets with increasing investment in healthcare infrastructure and a growing demand for pharmaceutical products.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Contract Development & Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Service, market is studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services. The Pharmaceutical Manufacturing Services commanded largest market share of 32.07% in 2023, followed by Drug Development Services.
Based on End User, market is studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma. The Big Pharma commanded largest market share of 44.59% in 2023, followed by Generic Pharmaceutical Companies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded largest market share of 37.17% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/pharmaceutical-contract-development-manufacturing?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Pharmaceutical Contract Development & Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Pharmaceutical Contract Development & Manufacturing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Pharmaceutical Contract Development & Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Holding GmbH, Almac Group Limited, Aurobindo Pharma Limited, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Curia Global, Inc., Danaher Corporation, Delwis Healthcare Pvt. Ltd., Evonik Industries AG, Fabbrica Italiana Sintetici S.p.A., Famar Health Care Services, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Grifols S.A., Jubilant Pharmova Limited, Lonza Group AG, Pfizer Inc., Recipharm AB, Samsung Biologics Co., Ltd., Siegfried AG, The Fareva Group, Thermo Fisher Scientific Inc., Vetter Pharma-Fertigung GmbH & Co. KG, and WuXi Biologics Co., Ltd..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Pharmaceutical Contract Development & Manufacturing Market, by Service
7. Pharmaceutical Contract Development & Manufacturing Market, by End User
8. Americas Pharmaceutical Contract Development & Manufacturing Market
9. Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market
10. Europe, Middle East & Africa Pharmaceutical Contract Development & Manufacturing Market
11. Competitive Landscape
12. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Pharmaceutical Contract Development & Manufacturing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Pharmaceutical Contract Development & Manufacturing Market?
3. What is the competitive strategic window for opportunities in the Pharmaceutical Contract Development & Manufacturing Market?
4. What are the technology trends and regulatory frameworks in the Pharmaceutical Contract Development & Manufacturing Market?
5. What is the market share of the leading vendors in the Pharmaceutical Contract Development & Manufacturing Market?
6. What modes and strategic moves are considered suitable for entering the Pharmaceutical Contract Development & Manufacturing Market?
Read More @ https://www.360iresearch.com/library/intelligence/pharmaceutical-contract-development-manufacturing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Contract Development & Manufacturing Market worth $222.04 billion by 2030, growing at a CAGR of 8.46% - Exclusive Report by 360iResearch here
News-ID: 3407633 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
